Clostridium Difficile Vaccine 2-Dose Versus 3-Dose Study

NCT03918629 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

1994

Enrollment

INDUSTRY

Sponsor class

Conditions

Clostridium Difficile Associated Disease

Interventions

BIOLOGICAL: Clostridium difficile
BIOLOGICAL: Placebo

Sponsor

Pfizer